Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Magnesium implicated in death from cardiovascular disease

July 11, 1997

TEI-A0225: new treatment for restenosis

July 11, 1997

Cardiovascular effects of psychotropic drugs

July 11, 1997

Chugai reports sydnonimine derivatives for angina

July 11, 1997

CPC-111 moves toward pivotal trials for bypass surgery

July 10, 1997

Yamanouchi, Ferring collaborate on endothelin antagonists

July 10, 1997

New lactam compounds for sepsis and RA

July 10, 1997

Low-dose combination of ramipril and felodipine evaluated in SHR

July 9, 1997

Fixed-dose losartan/hydrochlorothiazide combination now available in U.K.

July 8, 1997

Potent, selective and orally active ETA antagonist from Zeneca

July 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...